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Introduction. Intravascular lymphoma (IVL) is an uncommon and often fatal disease characterized by intraluminal proliferation of
lymphomatous cells within blood vessels. Because of a heterogeneous clinical presentation and lack of sensitive diagnostic protocols,
diagnosis of IVL is most often made at autopsy. However, with early diagnosis and appropriate chemotherapy, the prognosis is
greatly improved and complete remission is possible. In order to broaden the possible presentations of IVL, we present a patient
with an atypical manifestation of biopsy-proven intravascular large B-cell lymphoma who suﬀered dissections of both intracranial
and extracranial arteries in addition to progressive intracranial hemorrhages. Case Report. A 47-year-old woman presented with
unilateral paresthesias. She developed progressive multifocal infarcts and hemorrhage with dissections of both intracranial and
extracranial arteries, resulting in coma. Brain biopsy revealed IVL. She received aggressive chemotherapy and remains in complete
remission with good neurologic recovery. Conclusion. IVL is known to exert its pathology on small arteries and capillaries, but is
not known to cause dissections of large vessels. The diagnosis should be considered in cases with unexplained arterial dissections
and progressive strokes. Early diagnosis with appropriate laboratory screening and tissue conﬁrmation by biopsy can lead to greatly
improved outcomes.

1. Introduction
Intravascular lymphoma (IVL) is recognized by the World
Health Organization (WHO) as an extremely rare subtype of
diﬀuse extranodal large B-cell non-Hodgkin’s lymphoma with
an estimated annual incidence of 0.5 cases per 1,000,000 [1].
IVL leads to intraluminal proliferation of neoplastic lymphoid
cells in small and medium vessels [2]. These cells have lost the
ability for transvascular migration due to defects in adhesion
molecules [3]. IVL can involve any organ system, particularly
the central nervous system (CNS), and its protean neurological
manifestations often hinder diagnosis. Patients can present
with subacute encephalopathy or dementia, paralysis, seizures,

or multifocal cerebrovascular events, by order of frequency
[1, 4, 5]. Systemic symptoms vary, but fever and skin lesions
are the most common, whereas lymphadenopathy is usually
absent [2].
Serologic abnormalities include anemia (63%), high lactate dehydrogenase (LDH) (82%) and beta 2-microglobulin
levels (86%) [6]. Bone marrow involvement occurs in 32% of
patients, and cerebrospinal ﬂuid (CSF) rarely contains malignant cells [6]. Magnetic resonance imaging (MRI) is nonspeciﬁc and can be normal, though there are numerous reports
of rapid progression of cerebral infarcts [5]. Organ biopsy is
the gold standard for diagnosis of IVL but is frequently performed too late, and cases with CNS involvement are most
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Figure 1: (a) Left to right: computed tomography (CT), ﬂuid-attenuated inversion recovery (FLAIR), T1 post-contrast, and susceptibilityweighted imaging (SWI) 13 days after admission showed minimal ﬁndings on CT, but FLAIR hyperintensities and petechial hemorrhages on T1
and SWI images (arrows). These had progressed compared to initial imaging (not shown). (b) Left to right: Carotid and cerebral angiography
showing irregular corrugated and beaded appearance of the cervical carotid arteries and subtle intracranial vessel narrowing (arrows), and
two new foci of restricted diﬀusivity on diﬀusion weighted imaging (DWI) in the bilateral centrum semiovale consistent with interval infarcts
(arrows). Note: there was another infarct in the left centrum semiovale on an adjacent slice not shown above.

often diagnosed post-mortem (60%) [7]. Random skin biopsies may help make the diagnosis earlier, with up to 83% sensitivity even without skin ﬁndings on exam [8, 9]. While IVL
can have a grim prognosis with average untreated survival
only a few months from diagnosis, chemotherapies containing
rituxumab and doxorubicin have improved three-year survival
rates to 60%, which may be further increased when methotrexate is added [1, 10]. When diagnosed and treated promptly,
complete remission is seen in up to 42% of cases, although
recent survival data with adequate treatment are lacking [11].
We describe an unusual presentation of IVL with multiple
dissections of both intracranial and extracranial blood vessels
and progressive intracranial hemorrhages (ICH).

2. Case Report
A 47-year-old woman with a history of delayed gastric emptying presented with migratory paresthesias traveling up her
right side. These episodes occurred daily, lasted 20 minutes,
and were associated with headache and confusion. During the
month preceding her admission, she was admitted to an outside hospital with right-sided paresthesias, worsening

migraines with visual aura, and somnolence. Initial contrast-enhanced MRI of the brain did not have acute ﬁndings,
and showed minimal background nonspeciﬁc T2-weightedﬂuid-attenuated inversion recovery (FLAIR) hyperintensities
in the subcortical white matter.
After concern of a focal motor seizure, the patient was
transferred to our hospital. She had no lymphadenopathy, skin
lesions, or edema. Neurologically, she was initially somnolent
but easily arousable, and once alert remained interactive and
oriented suﬃcient to participate in the Montreal cognitive
assessment (MOCA). Her MOCA score was 22/30 with notable deﬁcits in attention, language and abstraction – a marked
departure from her high-functioning baseline. The remainder
of her neurologic exam was unremarkable. Laboratory evaluation including cerebrospinal ﬂuid analysis was unrevealing
(Table 1).
MRI of the brain was repeated 13 days after the initial scan
(Figure 1(a)), showing two new foci of restricted diﬀusivity in
the left centrum semiovale consistent with interval infarcts.
There was also progression of FLAIR hyperintensities in the
right anterior cingulate gyrus and inferior right and posterior
left frontal lobes, with corresponding areas of petechial
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Table 1: Additional laboratory ﬁndings.
Value
Comprehensive metabolic panel
142 mmol/L
Sodium
3.6 mmol/L
Potassium
108 mmol/L
Chloride
26 mmol/L
CO2
10 mg/dL
BUN
1.24 mg/dL
Creatinine
103 mg/dL
Glucose
9.2 mg/dL
Calcium
6.1 g/dL
Protein, total
4.1 g/dL
Albumin
0.7 mg/dL
Bilirubin
60 U/L
Alkaline phosphatase
17 U/L
AST
11 U/L
ALT
8 mmol/L
Anion gap
Complete blood count
3.73 k/µl
WBC
RBC
4.47 M/µl
HGB
13.3 g/dL
HCT
38.9%
86.9 fL
MCV
MCH
29.7 pg
34.2 g/dL
MCHC
14.8%
RDW
152 k/µl
Platelet
6.9 fL
MPV
63.4, 2.4 k/µl
Granulocyte %, #
9.1, 0.3 k/µl
Monocyte %, #
3.1, 0.1 k/µl
Eosinophil %, #
0.4, 0.0 k/µl
Basophil %, #
24, 0.9 k/µl
Lymphocyte %, #
Paraneoplastic autoantibody evaluation (CSF)
Negative
Neuronal nuclear Ab, Type 1
Negative
Neuronal nuclear Ab, Type 2
Negative
Neuronal nuclear Ab, Type 3
Negative
Glial Nuclear Ab
Purkinje cell cytoplasmic Ab,
Negative
Type 1
Purkinje cell cytoplasmic Ab,
Negative
Type 2
Purkinje cell cytoplasmic Ab,
Negative
Type Tr
Negative
Amphiphysin Ab
Negative
CRMP-5 IgG
Additional laboratory tests
427 U/L
LDHa
1,107 ng/mL
Ferritinb
1.83 mU/L
TSH
0.1 mg/dL
CRP
13.7 sec
Prothrombin time
1.1
INR
Sed rate, Westergren
2 mm/hr
a

Interpretation

*

High

*

Low

*

High
Low

*

%*High

*

High
High

*

LDH was analyzed 45 days after initial test results. bFerritin was analyzed 20
months after initial test results.

hemorrhage on T2*-weighted imaging. Continuous electroencephalograms (EEG) conﬁrmed encephalopathic slowing
without epileptiform discharges. Cerebral angiography showed
irregular corrugated and beaded appearance of the cervical
carotid arteries, thought to be consistent with chronic ﬁbromuscular dysplasia (Figure 1(b)). High-resolution vessel wall
MRI did not show arterial wall enhancement to suggest vasculitis. 18F-ﬂuorodeoxyglucose positron emission tomography (FDG-PET) scan of the brain (Figure 2) and computed
tomography (CT) of the chest, abdomen, and pelvis were
unrevealing.
As an extensive workup was thus far negative (CSF OCB,
ﬂow, cytology, HSV/VZV, ANA, ANCA, Mayo paraneoplastic
panel, VGKC, AQ4, NMDA, tox screen, EEG without obvious
seizure), the patient received a presumptive diagnosis of idiopathic encephalitis and was treated empirically with a ﬁveday trial of intravenous methylprednisolone followed by a
prednisone taper. She improved clinically for one month after
discharge and returned to work, but gradually developed worsening headache, vomiting, lethargy, and episodic left facial
droop. Repeat MRI (Figure 3(a)) showed marked interval
progression with new areas of cytotoxic edema/infarction,
vasogenic edema, and a moderate-sized right temporoparietal
hemorrhage causing cerebral edema and midline shift, with
additional petechial hemorrhages on T2*-weighted imaging.
There was extensive new sulcal FLAIR signal and enhancement compatible with blood-brain barrier breakdown.
CSF analysis demonstrated marked protein elevation
(140 mg/dL) without pleocytosis. Repeat catheter angiography
showed a new right cervical internal carotid artery dissection
in the distal extracranial portion as well as progression of luminal irregularities indicative of progressive vasculopathy
(Figure 3(b)). Magnetic resonance angiography (MRA) of the
head and neck the same day revealed additional bilateral vertebral artery dissections involving the entire right vertebral
artery and the left V3/4 segments, as well as new narrowing of
the bilateral temporal arteries. There was no instrumentation
above the level of the common carotid arteries or vertebral
artery origins during the initial catheter angiogram to explain
this ﬁnding. Our diﬀerential diagnosis expanded to include
atypical vasculitides, inﬂammatory amyloid angiopathy, complicated Posterior reversible encephalopathy syndrome (PRES),
and reversible cerebral vasoconstriction syndrome (RCVS), or
IVL (Table 2). Because an elevated LDH level in an atypical
case without infection can be suggestive of IVL, we measured
LDH and found hers to be elevated to 450 U/L (Table 1).
The patient’s clinical course progressed to coma due to
cerebral edema and hematoma expansion. A right temporoparietal brain biopsy was obtained. Sections stained with
hematoxylin-and-eosin showed small cortical vessels pathologically distended with neoplastic lymphocytes. These cells
were pleomorphic, hyperchromatic, and displayed prominent
nucleoli and occasional mitoses (Figure 4(a)). They did not
spill out into the surrounding neuropil. Immunohistochemistry
revealed these malignant cells to be diﬀusely positive for
CD20, a B-cell marker (Figure 4(b)). The tumor cells also
labeled widely for Mindbomb E3 Ubiquitin Protein Ligase 1
(MIB-1), a marker of proliferation. Based on these ﬁndings,
the patient was diagnosed with IVL. The patient was urgently
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Figure 2: (a) Left to right: Repeat CT, FLAIR, T1post, and SWI showing marked interval progression of hemorrhages on CT and SWI with
surrounding edema on FLAIR and subtle foci of enhancement on T1 post-contrast images (arrows). The vasogenic edema and moderatesized right temporoparietal hemorrhage caused cerebral edema and midline shift, and there were multiple additional petechial hemorrhages.
There was also new sulcal FLAIR signal with subtle enhancement consistent with blood-brain barrier breakdown. (b) Left to right: Repeat
catheter angiography showed a new right cervical internal carotid artery dissection on carotid angiography (arrow), progression of luminal
irregularities in the distal the middle cerebral artery and the anterior cerebral artery branches (arrows), and new areas of cytotoxic edema/
infarction on DWI (arrows).

started on chemotherapy with rituximab, cyclophosphamide,
doxorubicin, vincristine, and prednisone (R-CHOP) along
with decompressive craniectomy, which led to reversal of coma
and liberation from the ventilator several days later. She then
received methotrexate, which halted progression of her disease
and allowed her to return home with a modiﬁed Rankin Scale
of 1. The patient remains in remission today, four years later.

3. Discussion
IVL involving the CNS is an aggressive condition with a poor
prognosis because its protean clinical manifestations frequently preclude diagnosis. Laboratory and imaging tools
provide clues to the etiology, but lack adequate sensitivity and
speciﬁcity. Our patient exhibited an unusual presentation of
multiple arterial dissections and progressive ICH. She underwent an extensive workup for progressive encephalopathy
until her decline into coma necessitated a brain biopsy. The

pathological proliferation of intraluminal lymphocytes in the
small intracranial vessels explains our patient’s symptoms and
imaging ﬁndings. As arterioles, venules, and capillaries stagnate with malignant cells, intraparenchymal hemorrhage and
infarction can occur. However, the formation of multiple
large-artery dissections in her clinical course remains unexplained. Microvessels are a known source of intramural hematomas in the setting of arterial dissection and intraplaque
hemorrhage, attributed to vasa vasorum leakage or rupture
within the wall of carotid and vertebral arteries [12]. It is
unclear whether IVL is capable of inﬁltrating these small vessels (vasa vasorum) within the arterial wall to cause rupture
and dissection of the intima and adventitia of the artery.
Given the limitations of an individual reported case, we
cannot rule out an alternative etiology for her dissections. It
is possible that she had either underlying ﬁbromuscular dysplasia (FMD) or another condition explaining her dissections,
in addition to IVL explaining her brain ﬁndings. However, her
angiographic studies showed interval development of new
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Figure 3: (a) FDG-PET scan of the brain demonstrated mildly diminished FDG uptake in the left more than right bilateral temporal, frontal,
and parietal lobes as well as the in the posterior cingulate, precuneus and the primary visual and visual association cortices. The most prominent
metabolic reduction was in the left frontal association cortex. There were no focal areas of hypermetabolism in the mesial temporal lobes or
elsewhere. This diﬀuse pattern of mild metabolic changes was not speciﬁc for any inﬂammatory disease or other process, and most suggestive
of a global encephalopathy with asymmetry due to more pronounced deﬁcits in the left hemisphere. (b) PET scan of the body was notable
for bilateral pleural eﬀusions as well as pericardial eﬀusion and scattered nonspeciﬁc ill-deﬁned hypermetabolic pulmonary nodules with
diﬀerential including infectious/inﬂammatory process or pulmonary lymphoma with max SUV (standard uptake value) of 6.8.
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Table 2: Laboratory/imaging workup.

Diﬀerential diagnosis
Neurosarcoidosis
Cerebral sinus thrombosis
Vasculitis
Reversible cerebral vasoconstriction syndrome
Autoimmune and paraneoplastic encephalitis
CNS malignancy or metastasis
Infectious endocarditis with septic emboli
Encephalitis (Infectious etiologies)
Cerebral autosomal dominant arteriopathy
(a) with subcortical infarcts
and leukoencephalopathy (CADASIL)
Drug-induced vasculopathy
Amyloid angiitis
Progressive multifocal leukoencephalopathy

Labs/imaging
ACE
Catheter angiogram
ANA, ANCA, SSA, SSB, ESR, CRP, Hepatitis panel
Catheter angiogram and high resolution vessel wall MRI
VGKC, NMDA, CASPR2, LGI1 paraneoplastic antibody panel,
Cerebral FDG PET scan
CSF cytology and ﬂow cytometry, CT of the chest, abdomen, pelvis. PET of the brain
ESR, CRP, lactate
TB, RPR, HIV, VZV, HSV, EBV, WNV, HTLV1/2, and others
(b)

MRI

Urine drug screen
Congo red and thioﬂavin on biopsy, MRI with
Susceptibility-weighted imaging
HIV antibodies

Figure 4: (a) Hematoxylin-and-eosin of the brain biopsy showed small cortical vessels pathologically distended with neoplastic lymphocytes
(200X). (b) These cells were positive by immunohistochemistry for CD20, a B-cell marker (200X).

large-artery dissections associated with clinical and radiographic progression of her IVL. To date, there have been no
reports in the literature to support IVL involving large arteries
such as carotid and vertebral arteries, a disease known to
involve mainly arterioles, venules, and capillaries.
This case highlights the need for a high index of suspicion
for an underlying IVL in the setting of multiple intracranial
and extracranial dissections and ICH, and progression of ﬁndings despite standard medical therapy. Our patient recovered
from her coma and currently remains in remission four years
later owing to accurate histopathological diagnosis and
prompt treatment, which stands in stark contrast to the majority of patients who are diagnosed postmortem. In evaluating
progressive encephalitis of unclear etiology, prompt brain
biopsy proved essential in directing treatment. However, there
may be reasons when brain biopsy may be delayed or inaccurate due to concerns regarding procedural risk or when there
is little to no tumor mass formation, which could lead to non-

diagnostic results that have the potential to critically delay the
initiation of therapy. Imaging ﬁndings such as diﬀuse scattered
foci of T2 hyperintensities and diﬀusion restriction, petechial
and parenchymal hemorrhages, with or without arterial dissections should raise the suspicion for this elusive disease even
in the absence of detectable mass lesions. Early clinical diagnostic strategies may enable treatment sooner. These strategies
make the diagnosis by assimilating other important data
including serum tumor markers, LDH (lactate dehydrogenase) and soluble IL2R (interleukin-2 receptor), as well as
random skin and bone marrow biopsy with ﬂow cytometry
[6, 8, 9,13, 14]. In particular, CNS involvement of lymphoma
at diagnosis portends a worse prognosis and these patients
are thought to have a higher rate of relapse, especially in the
CNS [15]. It has been proposed that positive ﬁndings on skin
biopsy may be useful in cases without proven CNS disease as
a risk factor for later relapse in the CNS, though further investigation is needed to prove this [15]. There remains a need for
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better pathophysiologic understanding of this elusive
disease.
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